Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
posted on
Dec 22, 2020 01:03PM
COVID-19 treatments. The 40,000 ft view.....
As of the end of November, there are:
590+ drug development programs in the planning stages
390+ trials that have been reviewed by the FDA
90+ early stage trials testing safety and dosing
300+ late stage trials testing efficacy and safety